FDA Press Releases
FDA Press Releases
The feed below is an automatic RSS feed from the FDA website.
- FDA Roundup: January 25, 2022
- Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant
- FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19
- FDA Roundup: January 21, 2022
- FDA Roundup: January 18, 2022
- FDA Releases CDRH Health of Women Strategic Plan to Better Inform Medical Device Research and Regulation for All Women
- FDA Roundup: January 14, 2022
- FDA Releases Federal Interagency Working Group Scientific Opinions on Testing Methods for Asbestos in Talc-Containing Cosmetic Products
- FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species
- FDA Roundup: January 11, 2022
- FDA Roundup: January 7, 2022
- Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months
- FDA Roundup: January 4, 2022
- Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine
- Coronavirus (COVID-19) Update: December 28, 2021
